Proportion (95% CI) of IgG seropositivity to SARS-CoV-2 at baseline, 3-month, and 6- month follow-up by participants’ work and home council areas.</p
Background: Serological diagnosis has become an important tool to understand the extent of COVID-19 ...
We systematically reviewed the current understanding of human population immunity against SARS-CoV i...
Bidirectional seroconversion of IgG to SARS-CoV-2 at baseline, 3-month, and 6-month follow-up based ...
Seroprevalence of SARS -CoV-2 (seroprevalence = n/N*100, N = Total participants and n = SARS-COV-2 p...
Crude and adjusted seroprevalence of anti-SARS-CoV-2 antibodies at scheduled visits 3–5, stratified ...
BackgroundReports suggest that some persons previously infected with severe acute respiratory syndro...
Objective. To evaluate the seroprevalence of COVID-19 infection in pauci-symptomatic and asymptomati...
OBJECTIVE: To determine clinical and ethnodemographic correlates of serological responses against th...
Background: Health Care Workers (HCWs) are at higher risk for Covid19. Sero-surveillance among HCWs ...
OBJECTIVE To determine clinical and ethnodemographic correlates of serological responses against ...
This observational study evaluated SARS-CoV-2 IgG seroprevalence and related clinical, demographic, ...
Crude and adjusted seroprevalence of anti-SARS-CoV-2 antibodies at scheduled visits 1–6.</p
In the current study, we employed a large dataset, including 17,764 participants from Karachi, Lahor...
Aims: To assess SARS-CoV-2 seroprevalence over the first epidemic wave in the canton of Geneva, Swit...
BACKGROUND Estimates of seroprevalence to SARS-CoV-2 vary widely and may influence vaccination respo...
Background: Serological diagnosis has become an important tool to understand the extent of COVID-19 ...
We systematically reviewed the current understanding of human population immunity against SARS-CoV i...
Bidirectional seroconversion of IgG to SARS-CoV-2 at baseline, 3-month, and 6-month follow-up based ...
Seroprevalence of SARS -CoV-2 (seroprevalence = n/N*100, N = Total participants and n = SARS-COV-2 p...
Crude and adjusted seroprevalence of anti-SARS-CoV-2 antibodies at scheduled visits 3–5, stratified ...
BackgroundReports suggest that some persons previously infected with severe acute respiratory syndro...
Objective. To evaluate the seroprevalence of COVID-19 infection in pauci-symptomatic and asymptomati...
OBJECTIVE: To determine clinical and ethnodemographic correlates of serological responses against th...
Background: Health Care Workers (HCWs) are at higher risk for Covid19. Sero-surveillance among HCWs ...
OBJECTIVE To determine clinical and ethnodemographic correlates of serological responses against ...
This observational study evaluated SARS-CoV-2 IgG seroprevalence and related clinical, demographic, ...
Crude and adjusted seroprevalence of anti-SARS-CoV-2 antibodies at scheduled visits 1–6.</p
In the current study, we employed a large dataset, including 17,764 participants from Karachi, Lahor...
Aims: To assess SARS-CoV-2 seroprevalence over the first epidemic wave in the canton of Geneva, Swit...
BACKGROUND Estimates of seroprevalence to SARS-CoV-2 vary widely and may influence vaccination respo...
Background: Serological diagnosis has become an important tool to understand the extent of COVID-19 ...
We systematically reviewed the current understanding of human population immunity against SARS-CoV i...
Bidirectional seroconversion of IgG to SARS-CoV-2 at baseline, 3-month, and 6-month follow-up based ...